Cargando…
A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer
Stem cell-like colon cancer cells (SCCs) pose a major challenge in colon cancer treatment because of their resistance to chemotherapy and radiotherapy. Oncolytic virus-based therapy has shown promising results in uncured cancer patients; however, its effects on SCCs are not well studied yet. Here, w...
Autores principales: | Yoo, So Young, Bang, Seo Young, Jeong, Su-Nam, Kang, Dae Hwan, Heo, Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941329/ https://www.ncbi.nlm.nih.gov/pubmed/26918725 http://dx.doi.org/10.18632/oncotarget.7660 |
Ejemplares similares
-
Evolutionary cancer-favoring engineered vaccinia virus for metastatic hepatocellular carcinoma
por: Yoo, So Young, et al.
Publicado: (2017) -
A Cancer-Favoring, Engineered Vaccinia Virus for Cholangiocarcinoma
por: Yoo, So Young, et al.
Publicado: (2019) -
Oncolytic Vaccinia Virus in Lung Cancer Vaccines
por: Truong, Cao-Sang, et al.
Publicado: (2022) -
Oncolytic virotherapy targeting the IL15 pathway
por: Yoo, So Young, et al.
Publicado: (2023) -
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
por: Lee, Yu Seong, et al.
Publicado: (2020)